Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial


Creative Commons License

Demir A., Mandel N., Paydas S., Demir G., Er O. , Turhal N., ...Daha Fazla

BALKAN MEDICAL JOURNAL, cilt.37, ss.104-107, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Background: The synthesis of CDK4/6 inhibitors with endocrine treatment in two series of treatment has been widely accepted as the standard for patients with estrogen receptor-positive metastatic breast cancer. In spite of this, the activity of CDK4/6 inhibitors in patients with metastatic breast cancer who have progressed despite receiving multiple lines of treatment is not well understood.